VAXXA — Vaxxa AB Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vaxxa AB, formerly Augeo Group AB, is a Sweden-based IT company focused on auction operations. The Company's purpose is to conduct auction operations, sales and brokerage of mining, construction, loading, agricultural and construction machinery, trucks, passenger cars, motorcycles and off-road vehicles. Vaxxa AB also conducts wholesale trade in building materials as well as related activities. Vaxxa AB provides an auction site for individuals and companies who want to buy and sell objects in vehicles, machinery, construction and industry. Through personal support, financing solutions, the Company helps both buyers and sellers to do business. The Company's passion and motivation is to make the sales process more accessible to both individuals and companies, while striving to promote a more circular market.
Directors
- Last Annual
- Last Interim
- Incorporated
- August 10th, 2015
- Public Since
- October 26th, 2017
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- AktieTorget Stock Exchange
- Address
- Vastmannagatan 66, STOCKHOLM, 113 25
- Web
- https://ir.vaxxa.se/
- Phone
- +46 855920099
- Auditors
Similar to VAXXA
Aixia AB
AktieTorget Stock Exchange
Amido AB publ
AktieTorget Stock Exchange
Beyond Frames Entertainment AB (publ)
AktieTorget Stock Exchange
Blick Global AB (publ)
AktieTorget Stock Exchange
Comintelli AB
AktieTorget Stock Exchange
FAQ
As of Today at 23:55 UTC, shares in Vaxxa AB are trading at SEK0.71. This share price information is delayed by 15 minutes.
Shares in Vaxxa AB last closed at SEK0.71 and the price had moved by -17.06% over the past 365 days. In terms of relative price strength the Vaxxa AB share price has underperformed the FTSE Global All Cap Index by -19.13% over the past year.
There is no consensus recommendation for this security.
Find out moreVaxxa AB does not currently pay a dividend.
Vaxxa AB does not currently pay a dividend.
Vaxxa AB does not currently pay a dividend.
To buy shares in Vaxxa AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.71, shares in Vaxxa AB had a market capitalisation of .
Here are the trading details for Vaxxa AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: VAXXA
Based on an overall assessment of its quality, value and momentum Vaxxa AB is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vaxxa AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -57.79%.
As of the last closing price of SEK0.71, shares in Vaxxa AB were trading -40.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vaxxa AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Vaxxa AB's directors